Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

10.1158/1078-0432.CCR-21-4179

Saved in:

Bibliographic Details
Main Authors:	Lim, JSJ, Wong, ALA, Ow, SGW, Ngoi, NYL, Chan, GHJ, Ang, YLE, Chong, WQ, Lim, SE, Lim, YW, Lee, M, Choo, JRE, Tan, HL, Yong, WP, Soo, RA, Tan, DSP, Chee, CE, Sundar, R, Yadav, K, Jain, S, Wang, L, Tai, BC, Goh, BC, Lee, SC
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	American Association for Cancer Research (AACR) 2023
Subjects:	Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Breast Neoplasms Female Humans Letrozole Phenylurea Compounds Postmenopause Quinolines Receptor, ErbB-2 Receptors, Estrogen
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/236980
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1158/1078-0432.CCR-21-4179